Alfuzosin hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76282-302 -
Package NDC
76282-302-01 -
Package NDC
76282-302-05 -
Package NDC
76282-302-10 -
Package NDC
76282-302-12 -
Package NDC
76282-302-90 -
Application number
ANDA090284 -
SPL ID
663c0846-dc2c-409f-9fe0-bf2901ff92da -
SPL set ID
f075a897-7bef-4799-b7e2-7e051c461443 -
UNII
75046A1XTN -
RxCUI
861132
What the source publishes
- Labeler
- Exelan Pharmaceuticals Inc.
- Active ingredients
- Alfuzosin hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Alfuzosin hydrochloride",
"splId": "663c0846-dc2c-409f-9fe0-bf2901ff92da",
"labels": [
{
"setId": "f075a897-7bef-4799-b7e2-7e051c461443",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f075a897-7bef-4799-b7e2-7e051c461443",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f075a897-7bef-4799-b7e2-7e051c461443"
}
],
"routes": [
"ORAL"
],
"labeler": "Exelan Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-01)",
"package_ndc": "76282-302-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20121002"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-05)",
"package_ndc": "76282-302-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20121002"
},
{
"sample": false,
"description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-10)",
"package_ndc": "76282-302-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20121002"
},
{
"sample": false,
"description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-12)",
"package_ndc": "76282-302-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20221201"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-90)",
"package_ndc": "76282-302-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20190101"
}
],
"productId": "76282-302_663c0846-dc2c-409f-9fe0-bf2901ff92da",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "76282-302",
"deaSchedule": null,
"genericName": "Alfuzosin hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ALFUZOSIN HYDROCHLORIDE",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA090284",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20121002",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0376282302102",
"0376282302010",
"0376282302126"
],
"unii": [
"75046A1XTN"
],
"rxcui": [
"861132"
],
"spl_set_id": [
"f075a897-7bef-4799-b7e2-7e051c461443"
],
"manufacturer_name": [
"Exelan Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76282-302_663c0846-dc2c-409f-9fe0-bf2901ff92da"